Bioprinting is in the vanguard of the war against the novel coronavirus and holds promise for greater understanding of the way SAR-CoV-2 works in the human body.
ExOne Company and Xometry announced they will join together to provide metal 3D printing services.
Had IMTS 2020 taken place as scheduled, it would have been clear that making parts as quickly and cost-effectively as possible remains as the primary goal in manufacturing.
The advance of the novel coronavirus has had the entire world struggling with how to stay aware of and eliminate possible contamination—while still getting work done as efficiently as possible.
Speaking at the 3DHEALS 2020 virtual conference, Sam Onukuri from Johnson & Johnson discusses the emergence of 3D Printing in healthcare coinciding with new expectations from customers.
While 3D printing for dental applications is generally recognized as a mature technology, material innovation continues apace. An emerging trend has been for machine and material suppliers to augment their portfolios by working with or acquiring outside partners.
When the press reports on additive manufacturing, the line between what’s possible now and what may be coming in the future is sometimes blurry. People love to read about breakthroughs taking place in university labs and company R&D centers—the reports of which always include Star Trek-like possibilities of what those breakthroughs may portend.
The North American medical startup Marvel Medtech purchased an XJet Carmel 1400C 3D printer in the summer of 2019 to build key components in tools for fighting breast cancer.
The medical industry is constantly seeking out new, cutting-edge technologies to disrupt standard practices for the better.
Stratasys and Origin have signed an agreement in which Stratasys will market and promote Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S.
